{"nctId":"NCT00981825","briefTitle":"Efficacy of Salivary Bacteria and Post Brushing","startDateStruct":{"date":"2007-10"},"conditions":["Salivary Bacteria Levels"],"count":22,"armGroups":[{"label":"A","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Fluoride"]},{"label":"B","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Triclosan/Fluoride"]}],"interventions":[{"name":"Fluoride","otherNames":["fluoride toothpaste (Colgate Great Regular Flavor toothpaste)"]},{"name":"Triclosan/Fluoride","otherNames":["triclosan/fluoride toothpaste (Colgate Total toothpaste)"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male or female volunteers 18-65 years of age\n* Good general health\n* Must sign informed consent form\n* Must discontinue oral hygiene on the mornings of each appointment and between sampling periods.\n* No history of allergy to personal care consumer products, or their ingredients, relevant to any ingredient in the test products as determined by the dental/medical professional monitoring the study.\n\nExclusion Criteria:\n\n* Medical condition which requires pre-medication prior to dental procedures/visits\n* Medical condition which precludes eating/drinking for 12 hrs.\n* History of allergy to common dentifrice ingredients\n* Subjects unable or unwilling to sign the informed consent form.\n* Moderate or advanced periodontal disease.\n* 2 or more decayed untreated dental sites at screening.\n* Other disease of the hard or soft oral tissues.\n* Impaired salivary function (e.g. Sjogren's syndrome or head and neck irradiation).\n* Use of medications that can currently affect salivary flow\n* Current use of antibiotics\n* Use of antibiotics or antimicrobial drugs within 30 days prior to study visit #1.\n* Pregnant or nursing women.\n* Participation in any other clinical study within 30 days prior to enrollment into this study.\n* Use of tobacco products\n* Subjects who must receive dental treatment during the study dates.\n* Current use of Antibiotics for any purpose.\n* Immune compromised individuals (HIV,AIDS, immuno suppressive drug therapy)","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"CFU (Colony Forming Units)","description":"Total number of salivary bacterial colony forming units (lower number = less colonies present)","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.18","spread":"0.61"},{"groupId":"OG001","value":"6.94","spread":"0.40"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":22},"commonTop":[]}}}